Works matching IS 10648542 AND DT 2023 AND VI 32 AND IP 1/2
1
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 24
- Article
2
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 6
- Article
3
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 22
- Article
4
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 20
- Article
5
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 27
- Article
7
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 16
- Article
8
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 14
- Article
9
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 12
- Article
10
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 9
- Article
11
- 2023
- Question & Answer
12
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 7
- Article
13
- Applied Clinical Trials, 2023, v. 32, n. 1/2, p. 3
- Article